Diplomat Specialty Infusion Group Cincinnati Named Top Workplace
CINCINNATI, Ohio — June 5, 2017 — Diplomat Specialty Infusion Group’s Cincinnati location was named a Top Workplace in the greater Cincinnati and northern Kentucky region by the Cincinnati Enquirer.
The Cincinnati location of Diplomat Specialty Infusion Group, a brand of Diplomat Pharmacy, Inc. (NYSE: DPLO), has been awarded a Top Workplaces 2017 honor by the Cincinnati Enquirer.
Results are based on an employee survey administered by WorkplaceDynamics, LLC, a research firm specializing in organizational health and workplace improvement. The survey measures several aspects of workplace culture, including alignment, execution, and connection.
“Being named a Top Workplace is a remarkable triumph for our dedicated team members, who all play a pivotal role in our continued success,” said Phil Rielly, Diplomat vice president and president of Diplomat Specialty Infusion Group. “This achievement reflects Diplomat’s commitment to our employees and upholding a culture that values open communication, personal development, and respect while achieving results.”
To learn more about Diplomat’s career opportunities, visit diplomat.is/careers.
Diplomat Specialty Infusion Group launched in 2016 to unite certain Diplomat subsidiaries including BioRx, LLC, a Cincinnati-based company founded in 2004. Diplomat delivers treatments nationwide while offering customized programs to keep care personal.
BioRx was also named a Top Workplace in 2014 and 2015.
To learn more about Diplomat’s specialty infusion services, visit diplomat.is/specialtyinfusion.
Diplomat (NYSE: DPLO) is the nation’s largest independent provider of specialty pharmacy services—helping patients and providers in all 50 states. The company offers medication management programs for people with complex chronic diseases and delivers unique solutions for manufacturers, hospitals, payors, providers, and more. Diplomat opened its doors in 1975 as a neighborhood pharmacy with one essential tenet: “Take good care of patients and the rest falls into place.” Today, that tradition continues—always focused on improving patient care and clinical adherence. For more information, visit diplomat.is.
Kali Lucas, Public Relations Specialist
810.768.9580 | email@example.com
@DiplomatRx@JNJNews treatment Zytiga significantly cut the death risk for ... prostate cancer patients by 38% https://t.co/6Ga1okf4Ye @ASCO #ASCO174 days ago
@sloan_ketteringRT @sloan_kettering: Your immune system provides one of the best defenses against cancer. But sometimes it needs a little help. More about…1 week ago
@DiplomatRxThank you to @corpmagazine for recognizing Diplomat as a 2017 Michigan Economic Bright Spot awardee!2 weeks ago
@DiplomatRxFriend and Patient Advocate, Brenda Williams Hawkes was featured in @MyGoodDays Days this month!… https://t.co/TFGSoMecqO2 weeks ago
@DiplomatRxJeff Park Elected to Diplomat Board of Directors https://t.co/IMI1aRwNbm2 weeks ago